Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Abuhasira, 2021
RCTDPP-4 inhibitorstandard of careCOVID-19 severe or criticallysome concern
32/32 inconclusive
  • inconclusive 70 % increase in clinical improvement (28-day) (PE) with a moderate degree of certainty due to some concern in risk of bias
3 studies excluded by filtering options (0 RCT / 3 OBS)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).